Journal details
MOLECULAR THERAPY ONCOLOGY
CELL PRESS · eISSN 2950-3299
SCIEScopusDOAJ
Overview
MOLECULAR THERAPY ONCOLOGY. eISSN 2950-3299. published by CELL PRESS. United States. Oncology · Medicine, Research & Experimental. impact factor 8.5 (2025). JCR Q1. indexed in SCIE, Scopus, DOAJ. Figures below are the public fields already in this dataset. Confirm scope, APC and policies on the journal website before you submit.
Publication output
2026: 138 articles · 2025: 170 articles · 2024: 151 articles. Source: OpenAlex open data.
FAQ
What is the impact factor of MOLECULAR THERAPY ONCOLOGY?
The impact factor recorded for MOLECULAR THERAPY ONCOLOGY is 8.5 (2025 JCR release), JCR quartile Q1.
What is the CAS zone (Chinese Academy of Sciences ranking) of MOLECULAR THERAPY ONCOLOGY?
MOLECULAR THERAPY ONCOLOGY has no CAS zone in the current dataset.
Which databases index MOLECULAR THERAPY ONCOLOGY?
MOLECULAR THERAPY ONCOLOGY is indexed in SCIE, Scopus, DOAJ. Confirm on the journal website and the database itself before submitting.